French National Cancer Institute

Company

Related News

Multiple Oncology Trials Report Positive Results at ASCO 2026 and in Journals

Jun 02, 2026

Multiple oncology trials present recent results, including cabozantinib-nivolumab activity in non-clear cell RCC, savolitinib efficacy in MET-amplified gastric cancer, and induction nivolumab feasibility in HPV-driven oropharyngeal cancer.

Scientists Uncover How Cancer Hides From Immune System and Methods to Switch Off Cancer Genes

Feb 18, 2026

Researchers have identified how the MYC protein helps pancreatic cancer evade immune detection, while a separate team discovered methods to permanently switch off cancer genes in leukemia through epigenetic therapy targeting Menin and DOT1L proteins.